Tessa Therapeutics specializes in developing immunotherapies for solid tumors. Its platform focuses on redirecting the body's antiviral immune response to recognize and kill cancer cells, offering new treatment options for patients.
Euchloe Bio specializes in the discovery, development, engineering and commercialization of novel, fully-human antibodies for the treatment of cancer, using its proprietary antibody engineering technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.